In the second half of 2012, intellectual property issues were mostly discussed in the context of Russia’s accession to the World Trade Organization (WTO).
In the second half of 2012, intellectual property issues were mostly discussed in the context of Russia’s accession to the World Trade Organization (WTO).
There have been many such discussions involving a wide range of participants. This may seem strange because when Russia joined the WTO, its IP legislation had already been fully brought into conformity with minimum contained in the Agreement on the Trade-related Aspects of IP Rights (TRIPS).
However, a range of issues need additional legal regulation. One example is the issue of protecting data exclusivity. In 2010, the Federal Law On the circulation of medicines was adopted. This law established a prohibition on the disclosure of pre-clinical trials of medicines and clinical trials of medicines for a period of six years from when the medicine is registered.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
pharmaceuticals, WTO, TRIPS, Russian Civil Code
